News

The French Health Authority (Haute Autorite de Sante) granted Xience V an ASA Level IV medical benefit rating (Amelioration du Service Attendu) on recognizing the superior clinical results

The VersaCare bed system is a full-featured hospital bed designed to help deliver effective wound therapy, and improved outcomes for patients and their caregivers in acute care environments.

Results showed that there was no statistical difference in the mean change on AD Assessment Scale- Cognitive (ADAS-Cog) scores, the primary endpoint, after 16 weeks treatment with Huperzine

Cook has urged the court to issue a cease and desist order to prevent Edwards from manufacturing, importing, exporting, or selling the device, and has asked for an

With the acquisition, which is subject to DNAPrint Genomics shareholder approval, Nanobac becomes one of a select group of next-generation drug and diagnostics developers, applying advanced computational methods

The financing was led by Alta Partners and Clarus Ventures with participation from existing investors, including Sanderling Ventures, Tango and High Country Venture. Timothy Mills, chairman of the

The warrants have an exercise price of $12.50 per share and a term of 3 years. China Sky One Medical intends to use the proceeds from the offering

The company has said that Apoptone induces apoptosis by concomitantly increasing the expression of pro-apoptotic genes such as caspases, that can cause tumor cells to die, and reducing

BioHarp is a diagnostic medical device currently in development by U & I. BioHarp’s patented technology is expected to provide physicians with the capability to diagnose a variety